Analysis of the Global Biosimilars Market

Analysis of the Global Biosimilars Market

Impending Patent Expiries and Next-generation Biosimilars Pipeline Provide Impetus for Growth

RELEASE DATE
16-Jan-2014
REGION
Global
Research Code: M95E-01-00-00-00
SKU: LS00093-GL-MR_16934
AvailableYesPDF Download

$10,000.00

Special Price $7,500.00 save 25 %

In stock
SKU
LS00093-GL-MR_16934

$10,000.00

$7,500.00save 25 %

DownloadLink
ENQUIRE NOW

Description

Patent expirations of blockbuster biologics and a promising pipeline of biosimilars present positive opportunities for the global market. The research service provides analysis on regional market penetration and market dynamics. This study also provides a market overview, market engineering measurements, revenue forecasts, competitive analysis, and key trends for the biosimilars market and its segments. Regional analysis includes The United States, European countries such as the United Kingdom, Germany, France, Italy, Spain, Benelux, and Scandinavia as well as Asia-Pacific and Latin America. The study period is 2009–2019, with 2012 as the base year.

Table of Contents

Introduction

  • Title, Research Team, Table of Contents, List of Exhibits, and Methodology

Executive Summary

  • Executive Summary and Key Findings

Market Overview

  • Overview

Competitive Playbook

  • Market Outlook

Drivers and Restraints for Total Market

  • Overview

Forecasts and Trends for Total Market

  • Overview

Competitive Analysis

  • Overview

Key Companies to Watch

  • Overview

Europe Breakdown

  • Overview

The United States Breakdown

  • Overview

China Breakdown

  • Overview

India Breakdown

  • Overview

South Korea Breakdown

  • Overview

Japan Breakdown

  • Overview

Australia Breakdown

  • Overview

Latin America Breakdown

  • Overview

Brazil Breakdown

  • Overview

Mexico Breakdown

  • Overview

Argentina Breakdown

  • Overview

The Last Word

  • Overview

Appendix

  • Additional Information
Related Research
Prescription drug therapy for the treatment of obesity is experiencing a revival of interest with new government incentives and the recent approval of 2 new drugs, with 2 more pending imminent approval. This research service focuses on the competitive landscape of prescription drugs for the treatment of obesity. A global product and pipeline assessment is provided for marketed and investigational products. Segmentation by drug class is provided along with additional supporting information, such as clinical-trial timelines and results, historical and projected launch timelines, regulatory guidelines for clinical trial design and approval, and global epidemiology by region.
More Information
No Index No
Podcast No
Author Srinivas Sashidhar
WIP Number M95E-01-00-00-00
Is Prebook No